Rheumnow Podcast cover image

RheumNow Eular2023 Coverage - SLE Panel Discussion

Rheumnow Podcast

00:00

The Benefits of L-L-Das

Lumapana is a dual inhibitor of the B cell buff, which acts on eight ADCC receptors. Lumapana has been shown to be protective in terms of flare and damage if you reach L-L-DAS target. I think we need some actual randomized control trials because if we can reset someone's immune system in a disease like that where these people have filled a lot of drugs and a lot of them had nephritis. Like they weren't trivial disease. But anyway, so far so good on the B cells. One person had a bit of a relapse, it was retreated but not as bad as expected. And for auto antibodies from Lupus,. These people have

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app